These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 17372744)

  • 1. [Autoantibody profile in rheumatoid arthritis].
    Feist E; Egerer K; Burmester GR
    Z Rheumatol; 2007 May; 66(3):212-4, 216-8. PubMed ID: 17372744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Laboratory diagnostics of systemic autoimmune diseases. Part II: rheumatoid arthritis and vasculopathies].
    Hartung K; Seelig HP
    Z Rheumatol; 2007 May; 66(3):225-37; quiz 238. PubMed ID: 17429661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antibodies against citrullinated peptides in clinical practice and research].
    Engelmann R; Müller-Hilke B
    Z Rheumatol; 2009 Aug; 68(6):485-90. PubMed ID: 19578861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of high-throughput autoantibody profiling for the discovery of novel antigenic targets in rheumatoid arthritis.
    Somers K; Stinissen P; Somers V
    Ann N Y Acad Sci; 2009 Sep; 1173():92-102. PubMed ID: 19758137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-citrullinated protein/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis.
    Szodoray P; Szabó Z; Kapitány A; Gyetvai A; Lakos G; Szántó S; Szücs G; Szekanecz Z
    Autoimmun Rev; 2010 Jan; 9(3):140-3. PubMed ID: 19427413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Laboratory diagnostics for systemic sclerosis].
    Mierau R; Roers A; Genth E
    Z Rheumatol; 2007 May; 66(3):206, 208-11. PubMed ID: 17354003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbamylated vimentin represents a relevant autoantigen in Latin American (Cuban) rheumatoid arthritis patients.
    Martínez G; Gómez JA; Bang H; Martínez-Gamboa L; Roggenbuck D; Burmester GR; Torres B; Prada D; Feist E
    Rheumatol Int; 2016 Jun; 36(6):781-91. PubMed ID: 27038800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Association between bone catabolism and anti-citrullinated protein antibodies in rheumatoid arthritis].
    Harre U; Schett G
    Z Rheumatol; 2016 Oct; 75(8):809-811. PubMed ID: 27444625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies in rheumatoid arthritis and their clinical significance.
    Steiner G; Smolen J
    Arthritis Res; 2002; 4 Suppl 2(Suppl 2):S1-5. PubMed ID: 12110150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
    van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
    Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value.
    van Boekel MA; Vossenaar ER; van den Hoogen FH; van Venrooij WJ
    Arthritis Res; 2002; 4(2):87-93. PubMed ID: 11879544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies to citrullinated fibrinogen compared with anti-MCV and anti-CCP2 antibodies in diagnosing rheumatoid arthritis at an early stage: data from the French ESPOIR cohort.
    Nicaise-Roland P; Nogueira L; Demattei C; de Chaisemartin L; Rincheval N; Cornillet M; Grootenboer-Mignot S; Dieudé P; Dougados M; Cantagrel A; Meyer O; Serre G; Chollet-Martin S
    Ann Rheum Dis; 2013 Mar; 72(3):357-62. PubMed ID: 22580581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Novel immunodiagnostics for inflammatory arthritis].
    Wahle M; Kling E
    Z Rheumatol; 2016 May; 75(4):361-6. PubMed ID: 27142378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic strategies for autoimmune rheumatic diseases].
    Wiik AS
    Z Rheumatol; 2007 May; 66(3):219-20, 222-4. PubMed ID: 17380342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Usefulness of anti-citrullinated protein antibodies in the diagnosis and prognosis of rheumatoid arthritis].
    Bas S
    Rev Med Suisse; 2005 Mar; 1(10):674, 677-8, 680 passim. PubMed ID: 15828370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Early diagnosis of rheumatoid arthritis with a test based upon a specific antigen: cyclic citrullinated peptide].
    van Venrooij WJ; van de Putte LB
    Ned Tijdschr Geneeskd; 2003 Feb; 147(5):191-4. PubMed ID: 12645351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACPA (anti-citrullinated protein antibodies) and rheumatoid arthritis.
    Toes RE; van der Woude D
    Acta Reumatol Port; 2011; 36(3):205-7. PubMed ID: 22113596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An investigation of the added value of an ACPA multiplex assay in an early rheumatoid arthritis setting.
    van Heemst J; Trouw LA; Nogueira L; van Steenbergen HW; van der Helm-van Mil AH; Allaart CF; Serre G; Holmdahl R; Huizinga TW; Toes RE; van der Woude D
    Arthritis Res Ther; 2015 Oct; 17():276. PubMed ID: 26437716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to citrullinated proteins in arthritis: pathology and promise.
    Klareskog L; Widhe M; Hermansson M; Rönnelid J
    Curr Opin Rheumatol; 2008 May; 20(3):300-5. PubMed ID: 18388522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New autoanti-bodies in rheumatoid arthritis: anti-citrullinated protein or peptide autoanti-bodies and the others].
    Fabien N; Goetz J; Sordet C; Humbel RL; Sibilia J;
    Presse Med; 2008 Dec; 37(12):1756-66. PubMed ID: 18951757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.